Neutralization of Endogenous Granulocyte-Macrophage Colony-Stimulating Factor Subverts the Protective Immune Response toHistoplasma capsulatum
Open Access
- 1 November 1999
- journal article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 163 (9), 4985-4993
- https://doi.org/10.4049/jimmunol.163.9.4985
Abstract
We examined the influence of endogenous GM-CSF on the course of primary and secondary pulmonary histoplasmosis. A high proportion (≥75%) of C57BL/6 mice given mAb to GM-CSF did not survive primary infection, whereas 88–94% of infected controls survived. Analysis of leukocytes revealed significantly fewer CD4+ and CD8+ cells in lungs, but not airways, of anti-GM-CSF-treated mice as compared with infected controls. However, the histopathology was similar between the two groups. Lungs of mice given mAb to GM-CSF manifested depressed levels of TNF-α, IFN-γ, and reactive nitrogen intermediates and elevated levels of IL-4 and IL-10. Administration of mAb to IL-4, to IL-10, or both restored protective immunity in GM-CSF-neutralized mice. In secondary infection, administration of mAb to GM-CSF exacerbated infection but did not alter survival over 30 days. The character of the inflammatory response was similar, and no differences were detected in Th1 or Th2 cytokine production between the two groups. Thus, endogenous GM-CSF is essential for survival in primary but not secondary infection, and blockade perturbs protective immunity. These findings reveal a new mechanism whereby GM-CSF contributes to host protection and demonstrate differences in control of primary and secondary histoplasmosis.Keywords
This publication has 27 references indexed in Scilit:
- NITRIC OXIDE AND MACROPHAGE FUNCTIONAnnual Review of Immunology, 1997
- Modulation of Immune Responses in Murine Pulmonary HistoplasmosisThe Journal of Infectious Diseases, 1997
- Neutrophil oxygen radical generation. Synergistic responses to tumor necrosis factor and mono/polyunsaturated fatty acids.JCI Insight, 1996
- Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating FactorNew England Journal of Medicine, 1992
- Control of Granulocytes and Macrophages: Molecular, Cellular, and Clinical AspectsScience, 1991
- Histoplasmosis and AIDSThe Journal of Infectious Diseases, 1988
- Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide. Comparison with interferon gamma.The Journal of Experimental Medicine, 1987
- Role of the adherence-promoting receptors, CR3, LFA-1, and p150,95, in binding of Histoplasma capsulatum by human macrophages.The Journal of Experimental Medicine, 1987
- Recombinant human TNF induces production of granulocyte–monocyte colony-stimulating factorNature, 1986
- Induction of Macrophage Tumoricidal Activity by Granulocyte-Macrophage Colony-Stimulating FactorScience, 1986